4.1300
-0.4900
(-10.61%)
At close: April 10 at 4:00:02 PM EDT
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
212,847
130,386
50,636
70,518
Total Liabilities Net Minority Interest
14,781
198,322
143,848
141,412
Total Equity Gross Minority Interest
198,066
-67,936
-93,212
-70,894
Total Capitalization
198,066
-67,936
-93,212
-67,235
Common Stock Equity
198,066
-67,936
-93,212
-70,894
Capital Lease Obligations
6,259
572
1,901
--
Net Tangible Assets
198,066
-67,936
-93,212
-70,894
Working Capital
196,414
122,222
40,842
66,105
Invested Capital
198,066
-67,936
-89,264
-65,985
Tangible Book Value
198,066
-67,936
-93,212
-70,894
Total Debt
6,259
572
5,849
4,909
Net Debt
--
--
--
279
Share Issued
25,736.0760
27,055.7900
27,055.7900
27,055.7900
Ordinary Shares Number
25,736.0760
27,055.7900
27,055.7900
27,055.7900
12/31/2021 - 4/5/2024
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AARD Aardvark Therapeutics, Inc. Common Stock
7.02
-9.88%
SEPN Septerna, Inc.
5.16
-8.02%
MBX MBX Biosciences, Inc.
6.27
-2.03%
UPB Upstream Bio, Inc.
6.40
-1.99%
BCAX Bicara Therapeutics Inc.
10.15
-2.40%
BOLD Boundless Bio, Inc.
1.1900
-0.83%
SION Sionna Therapeutics, Inc.
7.66
-13.74%
SYRE Spyre Therapeutics, Inc.
11.93
-10.77%
MAZE Maze Therapeutics, Inc.
7.60
-4.64%
XNCR Xencor, Inc.
7.92
-10.10%